@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix ns2: . @prefix ns1: . @prefix prov: . @prefix ns3: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { ns1:develop . } sub:provenance { sub:assertion prov:generatedAtTime "2021-12-16T20:15:16.199353"^^xsd:dateTime; prov:wasGeneratedBy "S&T TWOC project version 2" . sub:version prov:value "2"^^xsd:integer . rdf:OBJECT rdfs:label "to treat COVID-19 but many report residual mental health problems after recovery" . rdf:OBJECT-POSITION rdfs:label "189"^^xsd:integer . rdf:PREDICATE rdfs:label "develop" . rdf:PREDICATE-POSITION rdfs:label "[34]" . rdf:SUBJECT rdfs:label "preventive vaccines and therapeutics such as remdesivir , dexamethasone , convalescent plasma , and others" . rdf:SUBJECT-POSITION rdfs:label "73"^^xsd:integer . rdfs:ABSTRACT-UID ns3:50 "olx19ybb" . rdfs:SENTENCE rdfs:label "Extensive efforts are underway to develop preventive vaccines and therapeutics such as remdesivir, dexamethasone, convalescent plasma, and others to treat COVID-19 but many report residual mental health problems after recovery." . rdfs:TRIPLE-UID ns2:olx19ybb-TRIPLE-ABSTRACT-2 "olx19ybb-TRIPLE-ABSTRACT-2" . rdfs:label "mental health" . rdfs:label "convalescent plasma" . } sub:pubInfo { sub:assertion prov:wasDerivedFrom . sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCSLeezU8JYlBsrgXOGXX4fxOq4oydsMzMK1CN0Rez2OEd2IYk18R4DetcZXwGhN3Pil7qcgNkiGvTirJXIo8zHl7jVehs19EdYtrttCKEaXRzWIr4LuCrfGedkvonEMWqR8e1GdQsLgEEyM50BD6Qw+srQt9ozcqf/9wG2MAMX9QIDAQAB"; npx:hasSignature "Mn1RtQXCG74o7aTbwewdyKjJ/gqbBcS/+W3+8wyQRJOZdAuIR105p70FEawMvR4U5hNjTln3mnw9gfRGmdQcHqGNxLNKjcl5gAzjzzIY3f1Hql7b/BVD/RHiehvLXovYaTtZeTxnBE7yjDbeLfLikYyeEjKNf9duRAvDlGyO49w="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-12-16T20:15:16.199353"^^xsd:dateTime; prov:wasAttributedTo . }